Wolverine Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.61M | Buy |
439,900
+183,700
| +72% | +$1.43M | ﹤0.01% | 1665 |
|
|
2025
Q2 | $2.15M | Buy |
256,200
+85,500
| +50% | +$620K | ﹤0.01% | 1654 |
|
|
2025
Q1 | $1.38M | Sell |
170,700
-36,400
| -18% | -$368K | ﹤0.01% | 1955 |
|
|
2024
Q4 | $1.93M | Buy |
207,100
+39,800
| +24% | +$384K | ﹤0.01% | 1992 |
|
|
2024
Q3 | $1.42M | Buy |
167,300
+4,400
| +3% | +$36.4K | ﹤0.01% | 2021 |
|
|
2024
Q2 | $1.59M | Sell |
162,900
-38,600
| -19% | -$471K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $3.04M | Sell |
201,500
-253,700
| -56% | -$4.6M | ﹤0.01% | 1319 |
|
|
2023
Q4 | $9.81M | Buy |
455,200
+142,200
| +45% | +$2.62M | 0.01% | 728 |
|
|
2023
Q3 | $5.82M | Buy |
313,000
+168,500
| +117% | +$3.93M | 0.01% | 902 |
|
|
2023
Q2 | $3.65M | Buy |
144,500
+1,100
| +0.8% | +$27.7K | ﹤0.01% | 1092 |
|
|
2023
Q1 | $3.5M | Sell |
143,400
-132,500
| -48% | -$3.55M | 0.01% | 1029 |
|
|
2022
Q4 | $6.53M | Buy |
+275,900
| New | +$7.44M | 0.01% | 764 |
|
|
2022
Q2 | – | Sell |
-353,900
| Closed | -$25.9M | – | 5691 |
|
|
2022
Q1 | $25.9M | Sell |
353,900
-76,800
| -18% | -$5.53M | 0.03% | 352 |
|
|
2021
Q4 | $40.6M | Buy |
430,700
+33,000
| +8% | +$3.94M | 0.05% | 272 |
|
|
2021
Q3 | $50.1M | Buy |
397,700
+1,900
| +0.5% | +$277K | 0.06% | 227 |
|
|
2021
Q2 | $67.8M | Buy |
395,800
+208,400
| +111% | +$33.8M | 0.11% | 136 |
|
|
2021
Q1 | $32.7M | Sell |
187,400
-10,200
| -5% | -$2.37M | 0.05% | 261 |
|
|
2020
Q4 | $40.2M | Buy |
197,600
+2,400
| +1% | +$488K | 0.06% | 204 |
|
|
2020
Q3 | $42.4M | Buy |
195,200
+52,400
| +37% | +$11.1M | 0.1% | 124 |
|
|
2020
Q2 | $26.8M | Sell |
142,800
-21,700
| -13% | -$3.8M | 0.07% | 180 |
|
|
2020
Q1 | $26.9M | Buy |
164,500
+58,000
| +54% | +$6.75M | 0.08% | 163 |
|
|
2019
Q4 | $8.87M | Buy |
106,500
+4,300
| +4% | +$327K | 0.02% | 732 |
|
|
2019
Q3 | $6.8M | Buy |
102,200
+42,200
| +70% | +$2.78M | 0.02% | 702 |
|
|
2019
Q2 | $3.98M | Sell |
60,000
-400
| -0.7% | -$23.3K | 0.01% | 1041 |
|
|
2019
Q1 | $3.36M | Sell |
60,400
-5,000
| -8% | -$305K | 0.01% | 1134 |
|
|
2018
Q4 | $3.17M | Sell |
65,400
-13,800
| -17% | -$844K | 0.01% | 1094 |
|
|
2018
Q3 | $6.84M | Buy |
79,200
+20,600
| +35% | +$1.47M | 0.02% | 766 |
|
|
2018
Q2 | $2.36M | Hold |
58,600
| – | – | 0.01% | 1459 |
|
|
2018
Q1 | $2.36M | Buy |
+58,600
| New | +$2.21M | 0.01% | 1459 |
|
|
2017
Q4 | – | Sell |
-22,000
| Closed | -$729K | – | 5458 |
|
|
2017
Q3 | $729K | Buy |
22,000
+8,800
| +67% | +$289K | ﹤0.01% | 2207 |
|
|
2017
Q2 | $465K | Sell |
13,200
-1,700
| -11% | -$49.5K | ﹤0.01% | 2504 |
|
|
2017
Q1 | $375K | Sell |
14,900
-1,800
| -11% | -$37.4K | ﹤0.01% | 2749 |
|
|
2016
Q4 | $276K | Buy |
16,700
+4,500
| +37% | +$76.4K | ﹤0.01% | 3355 |
|
|
2016
Q3 | $220K | Buy |
+12,200
| New | +$214K | ﹤0.01% | 3701 |
|
Other funds holding TDOC
Wolverine Trading's TDOC Position: Q3 2025 in Review
Wolverine Trading increased its Teladoc Health (TDOC) stake by 104% in Q3 2025, buying an estimated $96.5K and bringing the position to 24,209 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #4931.
Wolverine Trading first reported a position in TDOC in Q2 2017 and has held it in 28 quarters since. The position peaked at $15.3M in Q4 2020. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.
- Wolverine Trading held 24,209 shares of Teladoc Health worth $199K as of Q3 2025.
- Wolverine Trading bought 12,370 Teladoc Health shares in Q3 2025, an estimated $96.5K.
- Teladoc Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4931 holding.
- Wolverine Trading first reported a position in Teladoc Health in Q2 2017 and has held it in 28 quarters since.
- Wolverine Trading's Teladoc Health position peaked at $15.3M in Q4 2020.
- 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.